APA (7th ed.) Citation

Gerhardt, A., Dörfel, S., Schulz, H., Schlag, R., Vornholz, L., Nejad‐Asgari, S., & Welslau, M. (2024). Outcomes with ibrutinib in patients with chronic lymphocytic leukaemia: Results from the German multicentre REALITY study. European Journal of Haematology, 112(6), 927. https://doi.org/10.1111/ejh.14186

Chicago Style (17th ed.) Citation

Gerhardt, Anke, Steffen Dörfel, Holger Schulz, Rudolf Schlag, Lukas Vornholz, Sonja Nejad‐Asgari, and Manfred Welslau. "Outcomes with Ibrutinib in Patients with Chronic Lymphocytic Leukaemia: Results from the German Multicentre REALITY Study." European Journal of Haematology 112, no. 6 (2024): 927. https://doi.org/10.1111/ejh.14186.

MLA (9th ed.) Citation

Gerhardt, Anke, et al. "Outcomes with Ibrutinib in Patients with Chronic Lymphocytic Leukaemia: Results from the German Multicentre REALITY Study." European Journal of Haematology, vol. 112, no. 6, 2024, p. 927, https://doi.org/10.1111/ejh.14186.